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We have collaborated with the Yamagata Prefectural Health Authority in an epidemiological study of viral acute respiratory infections (ARIs) based on virus isolation at pediatric clinics as part of the National Epidemiological Surveillance of Infectious Diseases in Japan (1) . We carried out pilot molecular screening studies for human coronaviruses (HCoVs) using nasopharyngeal samples from children with ARIs. These studies revealed that 4 HCoVs (HCoV-229E, -OC43, -NL63, and -HKU1) were in circulation in Yamagata between 2010 and 2015 (2, 3) .
Although molecular and seroepidemiological studies have revealed the worldwide distribution of HCoV-229E (4), the virus has been isolated only in rare occasions. In general, the primary isolation of HCoV-229E is difficult, and HCoV-229E strains cannot be grown easily in cell cultures without extensive adaptation by passaging (4) . Secondary human embryonic kidney cells, human embryonic intestine MA-177 cells, the monkey kidney epithelial cell LLC-MK2 cell line, human embryonic fibroblasts, and the human colon epithelial cancer CaCo-2 cell line have been reported as permissive cells for the isolation of HCoV-229E from clinical specimens (5) (6) (7) . In addition, we have reported the isolation of HCoV-229E on rhabdomyosarcoma RD-18S cells by chance, which, when infected, showed picornavirus-like cytopathic effects (CPEs) (8) .
We next aimed to obtain an efficient cell culture system for the isolation of HCoVs, specifically for HCoV-229E, from clinical specimens. HeLa cells expressing angiotensin converting enzyme-2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) (HeLa-ACE2-TMPRSS2) (9) were kindly provided by the National Institute of Infectious Diseases for the isolation of HCoVs. Parental HeLa cells are known to express human aminopeptidase N (APN) and are permissive to HCoV-229E infection (10) . However, the use of HeLa-ACE2-TMPRSS2 for routine virus isolation is going to increase the probability of isolating not only HCoV-229E, but also HCoV-NL63 and severe acute respiratory syndrome coronavirus (SARS-CoV). We first confirmed that the sensitivity of HeLa-ACE2-TMPRSS2 cells for HCoV-229E was similar to parental HeLa cells cultured in minimum essential medium (MEM) containing trypsin (data not shown). In this study, we used HeLa-ACE2-TMPRSS2 cells for the propagation of a representative HCoV-229E strain (452-Yamagata-2008), which was isolated using RD-18S cells (8) , in MEM containing 5 mg/ml trypsin. This representative strain demonstrated more obvious CPEs in HeLa-ACE2-TMPRSS2 cells than in RD-18S cells. HCoV-229E-infected HeLa-ACE2-TMPRSS2 cells showed characteristic CPEs with large areas of fused cells resulting in syncytia formation. The characteristic CPEs observed in a HeLa-ACE2-TMPRSS2 cells may prove useful for the isolation of HCoV-229E strains from clinical specimens.
To confirm the difference in HCoV-229E sensitivity between HeLa-ACE2-TMPRSS2 and RD-18S cells, we compared the viral growth in both cell lines. Confluent cells in a 24-well plate were infected with the representative strain (452-Yamagata-2008) at a MOI of 0.001 and incubated for 60 min at 339 C. After washing twice with PBS(-), cells were incubated at 339 C in MEM containing 5 mg/ml trypsin. We collected both the culture medium and cells at 12, 24, 48, 72, and 96 h post-inoculation (p.i.) and stored them at -809 C until use in infectivity assays. The culture medium and infected cells were disrupted by freezing and thawing 3 times before performing infectivity assays. The assays were performed using the end-point dilution method with HeLa-ACE2-TMPRSS2 cells in MEM containing 5 mg/ml trypsin. Briefly, 10-fold serial dilutions were prepared from each supernatant after centrifugation, and 50 ml aliquots from each serial dilution were used to inoculate the monolayers in a 96-well plate (Greiner Bio-One, Frickenhausen, Germany). Four wells per dilution were used, and the 50z tissue culture infectious dose (TCID 50 ) of each supernatant was calculated using the K äarber method. As shown in Fig. 1 , virus titers in the HeLa-ACE2-TMPRSS2 cells increased more rapidly than did those in RD-18S cells. The yields of HCoV-229E in HeLa-ACE2-TMPRSS2 cells were 10-fold higher than those in the RD-18S cells at 48 h p.i. (P ＜ 0.05). We ob- Fig. 2A and B ).
Observation at 36 h p.i. revealed more massive syncytia formations in HeLa-ACE2-TMPRSS2 cells than in RD-18S cells (Fig. 2C and D) The CPEs observed were of characteristic appearance with large areas of cells fused to form syncytia (Fig. 2C) . Our findings suggest that HeLa-ACE2-TMPRSS2 cells have higher sensitivity to HCoV-229E than RD-18S cells. One of the reasons for the higher sensitivity may be the property of the parental HeLa cells. Besides, TMPRSS2 cleaves the HCoV-229E spike (S) protein thereby increasing spike driven cell-cell fusion (11) . Note that we used MEM supplemented with trypsin, and therefore it is not clear which protease (TMPRSS2 or trypsin) is primarily responsible for the activation of the HCoV-229E S protein in these cells. ACE2 is a receptor for HCoV-NL63 but not for HCoV-229E, thus it is not involved in HCoV-229E infection. Because of their possible susceptibility to a wide range of HCoVs, it is advantageous for ARI research to include HeLa-ACE2-TMPRSS2 cells in the cell system used for virus isolation.
The clear syncytia formation observed on HeLa-ACE2-TMPRSS2 cells will be helpful for virus isolation from clinical specimens. It is known that virus isolation in the proper cells is important for further viral studies. Now that we are able to propagate HCoV-229E more efficiently by using HeLa-ACE2-TMPRSS2 cells, we can continue our longitudinal epidemiological analysis of HCoV-229E based on virus isolation.
